Tapal-Er 50Mg 15Tablets

babies: not applicable. lactating mothers: it is unsafe to use this medicine during breastfeeding. studies have shown that the drug causes harm to the baby. pregnancy: it is unsafe to use this medicine during pregnancy.
human studies have shown that the drug causes harmful effects on the developing baby. seek the doctor's advice before using this medicine. alcohol: it is unsafe to consume alcohol while taking this medicine. driving: this medicine causes dizziness, blurred vision, and affects your ability to drive.
do not drive if you experience these symptoms. kidney: this medicine should be used with caution in patients with kidney disease.
dose adjustment is required. seek a doctor's advice before taking this medicine.
it is not recommended in patients with kidney disease. liver: this medicine should be used with caution in patients with liver diseases. studies have shown that dose adjustment is required in these patients.
seek a doctor's advice before using this medicine. this medicine is not recommended in patients with severe liver disease..

nausea vomiting dizziness sleepiness.

tapal er belongs to the class of analgesics used to treat moderate to severe pain. it relieves toothache, headache, period pain, joint and muscle pain.
it works by blocking the chemical messengers in the brain that cause pain..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this medicine with or without food as prescribed by your doctor • to get better results to take this medicine at a fixed time • finish the entire course of this medicine. • inform your doctor if you have pancreatic disease, asthma, and severe constipation before taking this medicine. • if you experience nausea, dizziness, vomiting, and sleepiness while taking this medicine, inform your doctor..

major • tapal er + aripiprazole: concurrent use of these medicines lead to an increase in the risk of central nervous system depression • tapal er + amitriptyline: concurrent use of these medicines lead to an increase in the risk of heart rate • tapal er + baclofen: concurrent use of these medicines lead to an increase in the risk of central nervous system depression • tapal er + clozapine: concurrent use of these medicines lead to an increase in the risk of central nervous system depression • tapal er + dantrolene: concurrent use of these medicines lead to an increase in the risk of central nervous system depression moderate • tapal er + albuterol: concurrent use of these medicines lead to an increase in the risk of blood pressure and heart rate • tapal er + bromocriptine: concurrent use of these medicines lead to an increase in the risk of dizziness and confusion • tapal er + cetirizine: concurrent use of these medicines lead to an increase in the risk of dizziness and confusion • tapal er + dobutamine: concurrent use of these medicines lead to an increase in the risk of blood pressure and heart rate • tapal er + formoterol: concurrent use of these medicines lead to an increase in the risk of blood pressure and heart rate.